Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

被引：0
|
作者：
Olagunju, Adeniyi [2 ,3 ]
Owen, Andrew [3 ]
Creesey, Tim R. [1 ,4 ,5 ]
机构：
[1] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Program HIV Prevent & Treatment, Chiang Mai, Thailand
[2] Obafemi Awolowo Univ, Fac Pharm, Ife, Nigeria
[3] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Inst Rech Dev, UMI 174, Marseille, France
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 13期
基金：
英国医学研究理事会;
关键词：
antiretrovirals; drug transporters; highly active antiretroviral therapy; HIV; pregnancy; prevention of mother-to-child transmission; HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; REVERSE-TRANSCRIPTASE INHIBITOR; HIV-INFECTED PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; MULTIDRUG-RESISTANT HIV-1; CONSTITUTIVE ANDROSTANE RECEPTOR; NEVIRAPINE PLASMA-CONCENTRATIONS; STEADY-STATE PHARMACOKINETICS; AMNIOTIC-FLUID ACCUMULATION;
D O I：
10.2217/PGS.12.138
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Mother-to-child-transmission rates of HIV in the absence of any intervention range between 20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy, delivery and breastfeeding can reduce HIV transmission to less than 2%. Physiological changes during pregnancy can influence ARV disposition. Associations between SNPs in genes coding for metabolizing enzymes, and/or transporters, and ARVs disposition are well described; however, relatively little is known E bout the influence of these SNPs on ARV pharmacokinetics during pregnancy and lactation as well as their effect on distribution into the fetal compartment and breast milk excretion. Differences in maternal, fetal and infant ARV exposure due to SNPs may affect the efficacy and safety of ARVs used to prevent mother-to-child-transmission. The aim of this review is to provide an update on the effect of pregnancy-induced changes on the pharmacokinetics of ARVs and highlight the potential role of pharmacogenetics.
引用
收藏
页码：1501 / 1522
页数：22
相关论文
共 50 条
  • [1] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Kaplan, Sigal
    Zeygarnik, Mikhail
    Stern, Tal
    [J]. DRUG SAFETY, 2022, 45 (04) : 345 - 357
  • [2] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Sigal Kaplan
    Mikhail Zeygarnik
    Tal Stern
    [J]. Drug Safety, 2022, 45 : 345 - 357
  • [3] DESIGN OF A GLOBAL, MULTICENTER STUDY TO ASSESS MATERNAL, FETAL, AND INFANT OUTCOMES OF PEGVALIASE EXPOSURE DURING PREGNANCY AND BREASTFEEDING
    Clague, Gillian
    Longo, Nicola
    Decker, Celeste
    Hunt, JoEllen
    Sazova, Ogun
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 67 - 67
  • [4] Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure
    Hudson, Rachel E. E.
    Metz, Torri D. D.
    Ward, Robert M. M.
    McKnite, Autumn M. M.
    Enioutina, Elena Y. Y.
    Sherwin, Catherine M. M.
    Watt, Kevin M. M.
    Job, Kathleen M. M.
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants
    Fogel, Jessica M.
    Mwatha, Anthony
    Richardson, Paul
    Brown, Elizabeth R.
    Chipato, Tsungai
    Alexandre, Michel
    Moodley, Dhayendre
    Elbireer, Ali
    Mirochnick, Mark
    George, Kathleen
    Mofenson, Lynne M.
    Zwerski, Sheryl
    Coovadia, Hoosen M.
    Eshleman, Susan H.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (04) : E164 - E169
  • [6] Maternal cadmium exposure during pregnancy and fetal development
    Kippler, Maria
    Tofail, Fahmida
    Wagatsuma, Yukiko
    Gardner, Renee
    Hamadani, Jena
    Rahman, Anisur
    Vahter, Marie
    [J]. TOXICOLOGY LETTERS, 2012, 211 : S143 - S143
  • [7] Maternal Hypothyroxinemia During Pregnancy and Growth of the Fetal and Infant Head
    Nina H. van Mil
    Régine P. M. Steegers-Theunissen
    Jacoba J. Bongers-Schokking
    Hanan El Marroun
    Akhgar Ghassabian
    Albert Hofman
    Vincent W. V. Jaddoe
    Theo J. Visser
    Frank C. Verhulst
    Yolanda B. de Rijke
    Eric A. P. Steegers
    Henning Tiemeier
    [J]. Reproductive Sciences, 2012, 19 : 1315 - 1322
  • [8] Maternal Hypothyroxinemia During Pregnancy and Growth of the Fetal and Infant Head
    van Mil, Nina H.
    Steegers-Theunissen, Regine P. M.
    Bongers-Schokking, Jacoba J.
    El Marroun, Hanan
    Ghassabian, Akhgar
    Hofman, Albert
    Jaddoe, Vincent W. V.
    Visser, Theo J.
    Verhulst, Frank C.
    de Rijke, Yolanda B.
    Steegers, Eric A. P.
    Tiemeier, Henning
    [J]. REPRODUCTIVE SCIENCES, 2012, 19 (12) : 1315 - 1322
  • [9] The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey
    Morris, P
    Binienda, Z
    Gillam, MP
    Harkey, MR
    Zhou, C
    Henderson, GL
    Paule, MG
    [J]. NEUROTOXICOLOGY AND TERATOLOGY, 1996, 18 (02) : 147 - 154
  • [10] Maternal risk exposure during pregnancy and infant birth weight
    Slemming, Wiedaad
    Bello, Braimoh
    Saloojee, Haroon
    Richter, Linda
    [J]. EARLY HUMAN DEVELOPMENT, 2016, 99 : 31 - 36
12345